Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
America Great HealthAAGH Days Payable is 9,204.84 as of Dec. 2025, which is 92% above its 10-year median of 4,784.18. The stock has 4 warning signs investors should review. Among 702 Biotechnology companies, America Great Health ranks better than 92.88% on this metric.
The historical rank and industry rank for America Great Health's Days Payable or its related term are showing as below:
AAGH'
s Days Payable Range Over the Past 10 Years
Min: 133.41 Med: 4784.18 Max: 15064.07
Current: 3736.1
During the past 13 years, America Great Health's highest Days Payable was 15064.07. The lowest was 133.41. And the median was 4784.18.
AAGH's Days Payable is ranked better than 92.88% of 702
companies
in the Biotechnology industry
Industry Median: 113.1
vs AAGH: 3736.10
America Great Health's Days Payable
declined
from Dec. 2024 (16,544.77) to Dec. 2025 (9,204.84).
It may suggest that America Great Healthaccelerated paying its suppliers.
America Great Health Days Payable Related Terms
America Great Health Days Payable Historical Data
* Premium members only.
The historical data trend for America Great Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, America Great Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
America Great Health Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, America Great Health's Days Payable distribution charts can be found below:
* The bar in red indicates where America Great Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
America Great Health's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
America Great Health (AAGH) has a Days Payable of 9,204.84 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on America Great Health and its competitors. This is 92% above median its historical median of 4,784.18. Over the past decade, America Great Health's Days Payable has ranged from 133.41 to 15,064.07. According to the industry distribution chart, America Great Health ranks #50 out of 702 companies in the Biotechnology industry, placing it in the top 7.1%.
Is America Great Health's Days Payable too high?
America Great Health's current Days Payable of 9,204.84 is 92% above median its 10-year median of 4,784.18. Over the past 10 years, this metric has ranged from a low of 133.41 to a high of 15,064.07. The Biotechnology industry median Days Payable is 113.10. America Great Health's value of 9,204.84 is 8038.7% above this industry median. Based on the distribution chart, America Great Health ranks #50 out of 702 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does America Great Health's Days Payable compare to ADTX and PKTX?
According to the Biotechnology industry distribution chart, America Great Health ranks #50 out of 702 companies for Days Payable. This places America Great Health in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.10. America Great Health's value of 9,204.84 is 8038.7% above this benchmark. Historically, America Great Health's own Days Payable has ranged from 133.41 to 15,064.07 over the past decade. While the company's 10-year median is 4,784.18 vs. the industry median of 113.10, America Great Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. America Great Health's current Days Payable of 9,204.84 is 8038.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on America Great Health and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. America Great Health's current Days Payable is 9,204.84, which is 92% above median its own 10-year median of 4,784.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is America Great Health stock overvalued right now?
America Great Health (AAGH) has a current Days Payable of 9,204.84. The current Days Payable is 9,204.84, which is 92% above median its 10-year median of 4,784.18 and 8038.7% above the Biotechnology industry median of 113.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For America Great Health (AAGH), the current Days Payable is 9,204.84 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AAGH has been successfully added to your 
